EP1773313A4 - Steuerung von biofilmbildung - Google Patents

Steuerung von biofilmbildung

Info

Publication number
EP1773313A4
EP1773313A4 EP05791709A EP05791709A EP1773313A4 EP 1773313 A4 EP1773313 A4 EP 1773313A4 EP 05791709 A EP05791709 A EP 05791709A EP 05791709 A EP05791709 A EP 05791709A EP 1773313 A4 EP1773313 A4 EP 1773313A4
Authority
EP
European Patent Office
Prior art keywords
control
biofilm formation
biofilm
formation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP05791709A
Other languages
English (en)
French (fr)
Other versions
EP1773313A2 (de
Inventor
Gary R Eldridge
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US11/085,279 external-priority patent/US7604978B2/en
Priority claimed from US11/133,858 external-priority patent/US20060264411A1/en
Application filed by Individual filed Critical Individual
Publication of EP1773313A2 publication Critical patent/EP1773313A2/de
Publication of EP1773313A4 publication Critical patent/EP1773313A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/203—Retinoic acids ; Salts thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/21—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pseudomonadaceae (F)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/245—Escherichia (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/285—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pasteurellaceae (F), e.g. Haemophilus influenza
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
EP05791709A 2004-07-14 2005-07-14 Steuerung von biofilmbildung Withdrawn EP1773313A4 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US58768004P 2004-07-14 2004-07-14
US60976304P 2004-09-14 2004-09-14
US11/085,279 US7604978B2 (en) 2004-07-14 2005-03-21 Inhibition of biofilm formation
US11/133,858 US20060264411A1 (en) 2005-05-20 2005-05-20 Control of biofilm formation
PCT/US2005/024946 WO2006010147A2 (en) 2004-07-14 2005-07-14 Control of biofilm formation

Publications (2)

Publication Number Publication Date
EP1773313A2 EP1773313A2 (de) 2007-04-18
EP1773313A4 true EP1773313A4 (de) 2007-11-07

Family

ID=35785807

Family Applications (1)

Application Number Title Priority Date Filing Date
EP05791709A Withdrawn EP1773313A4 (de) 2004-07-14 2005-07-14 Steuerung von biofilmbildung

Country Status (3)

Country Link
EP (1) EP1773313A4 (de)
CA (1) CA2573494A1 (de)
WO (2) WO2006010147A2 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7604978B2 (en) 2004-07-14 2009-10-20 Sequoia Sciences, Inc. Inhibition of biofilm formation
WO2006031943A1 (en) 2004-09-14 2006-03-23 Eldridge Gary R Compounds, compositions and methods for controlling biofilms and bacterial infections
TWI413646B (zh) * 2010-09-03 2013-11-01 Univ China Medical 用於抑制基質金屬蛋白酶活性及／或生成、抑制有絲分裂原活化蛋白激酶磷酸化、及／或促進膠原蛋白生成之醫藥組合物及其用途
CN102784096B (zh) * 2011-05-18 2016-10-12 上海现代药物制剂工程研究中心有限公司 一种积雪草酸自微乳化给药系统及其制备方法
US8324264B1 (en) 2011-07-22 2012-12-04 Sequoia Sciences, Inc. Inhibitors of bacterial biofilms and related methods
WO2013021258A1 (en) * 2011-08-05 2013-02-14 Council Of Scientific & Industrial Research Anti-tubercular compounds
EP2712863B1 (de) * 2012-09-28 2014-10-22 Sequoia Sciences, Inc. Neue Hemmer bakterieller Biofilme und zugehörige Verfahren
MX366684B (es) * 2012-12-06 2019-07-19 Colgate Palmolive Co Gel oral para el alivio de dolor dental.
CN108358991B (zh) * 2018-02-01 2020-11-10 云南中烟工业有限责任公司 一种澄广花中的三萜类化合物及其制备方法和应用
CN110141572B (zh) * 2019-06-20 2020-05-12 牡丹江医学院 一种治疗哮喘的药物及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5985601A (en) * 1995-06-05 1999-11-16 Human Genome Sciences, Inc. DNA encoding human cystatin E
FR2750326B1 (fr) * 1996-06-28 1998-07-31 Oreal Composition cosmetique et/ou dermatologique acide contenant un poly(acide 2-acrylamido 2-methylpropane sulfonique) reticule et neutralise a au moins 90 %
US6264926B1 (en) * 1999-02-12 2001-07-24 Council Of Scientific And Industrial Research Formulation useful as a natural herbal tooth powder
US6669929B1 (en) * 2002-12-30 2003-12-30 Colgate Palmolive Company Dentifrice containing functional film flakes

Non-Patent Citations (9)

* Cited by examiner, † Cited by third party
Title
BELOIN C ET AL: "Finding gene-expression patterns in bacterial biofilms", TRENDS IN MICROBIOLOGY, ELSEVIER SCIENCE LTD., KIDLINGTON, GB, vol. 13, no. 1, January 2005 (2005-01-01), pages 16 - 19, XP004705447, ISSN: 0966-842X *
DONLAN RODNEY M ET AL: "Biofilms: Survival mechanisms of clinically relevant microorganisms", CLINICAL MICROBIOLOGY REVIEWS, vol. 15, no. 2, April 2002 (2002-04-01), pages 167 - 193, XP002438976, ISSN: 0893-8512 *
HALL-STOODLEY LUANNE ET AL: "Bacterial biofilms: From the natural environment to infectious diseases", NATURE REVIEWS MICROBIOLOGY, vol. 2, no. 2, February 2004 (2004-02-01), pages 95 - 108, XP002438975, ISSN: 1740-1526 *
KAPLAN J B: "Methods for the treatment and prevention of bacterial biofilms", EXPERT OPINION ON THERAPEUTIC PATENTS, ASHLEY PUBLICATIONS, GB, vol. 15, no. 8, 2005, pages 955 - 965, XP002383461, ISSN: 1354-3776 *
LOCHOWSKA A ET AL: "Functional dissection of the LysR-type CysB transcriptional regulator. Regions important for DNA binding, inducer response, oligomerization, and positive control", JOURNAL OF BIOLOGICAL CHEMISTRY, AMERICAN SOCIETY OF BIOLOCHEMICAL BIOLOGISTS, BIRMINGHAM,, US, vol. 276, no. 3, 19 January 2001 (2001-01-19), pages 2098 - 2107, XP002295378, ISSN: 0021-9258 *
MAH THIEN-FAH C ET AL: "Mechanisms of biofilm resistance to antimicrobial agents", TRENDS IN MICROBIOLOGY, vol. 9, no. 1, January 2001 (2001-01-01), pages 34 - 39, XP002438506, ISSN: 0966-842X *
REN ET AL: "Differential gene expression for investigation of Escherichia coli biofilm inhibition by plant extract ursolic acid", APPLIED AND ENVIRONMENTAL MICROBIOLOGY, WASHINGTON,DC, US, vol. 71, no. 7, July 2005 (2005-07-01), pages 4022 - 4034, XP002365546, ISSN: 0099-2240 *
See also references of WO2006010147A2 *
STANLEY NICOLA R ET AL: "Identification of catabolite repression as a physiological regulator of biofilm formation by Bacillus subtilis by use of DNA microarrays", JOURNAL OF BACTERIOLOGY, WASHINGTON, DC, US, vol. 185, no. 6, March 2003 (2003-03-01), pages 1951 - 1957, XP002301705, ISSN: 0021-9193 *

Also Published As

Publication number Publication date
WO2006010147A2 (en) 2006-01-26
WO2006019881A3 (en) 2006-09-08
WO2006019881A2 (en) 2006-02-23
CA2573494A1 (en) 2006-01-26
EP1773313A2 (de) 2007-04-18
WO2006010147A3 (en) 2006-07-06

Similar Documents

Publication Publication Date Title
GB2428443B (en) Methods of well control
IL181587A0 (en) Production of ??-abeta
EP1773313A4 (de) Steuerung von biofilmbildung
HK1121497A1 (en) Production of tnfr-fc tnfr-fc
IL180742A0 (en) Method of manufacture
HK1079888A1 (en) Remote controlling
IL185757A0 (en) Methods of decreasing calcifcation
PT2102192E (pt) Formas de estado sólido de ilaprazole racémico
HK1161122A1 (en) Use of 24-norudca 24-norudca
HK1112710A1 (en) Reducing by-catch of seabirds
EP1931370A4 (de) Verwendung von des-aspartat-angiotensin i
ZA200804845B (en) Bubbling brick
AU302624S (en) Plumbing control
GB0410299D0 (en) Inhibition of biofilm formation
IL178683A0 (en) Methods of diminishing co-abuse potenitial
ZA200508325B (en) Manufacture of kerbstones
GB0412138D0 (en) Definition of zeroclick
GB0506135D0 (en) Controlling use of content
GB2416051B (en) Selection of component
GB0420727D0 (en) Comparison of patterns
AU2004905330A0 (en) Construction of amahs
ZA200903491B (en) Solid state forms of racemic ilaprazole
GB0407075D0 (en) Manufacture of cardboard
GB0503944D0 (en) Comparison of patterns
GB0510013D0 (en) Interaction of SNEV

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20070206

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20071010

17Q First examination report despatched

Effective date: 20090205

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20130201